Description

Shelter Pharma Limited lists 861,000 equity shares issued at Rs. 42.25 per share on preferential basis pursuant to conversion of warrants, effective January 21, 2026.

Summary

BSE has announced the listing and trading commencement of 861,000 equity shares of Shelter Pharma Limited (Scrip Code: 543963) effective January 21, 2026. These shares were issued to non-promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 42.25 per share (face value Rs. 10.00 with premium of Rs. 32.25). The shares rank pari-passu with existing equity shares.

Key Points

  • 861,000 equity shares listed with effect from January 21, 2026
  • Scrip Code: 543963
  • Face Value: Rs. 10.00 per share
  • Issue Price: Rs. 42.25 per share (including premium of Rs. 32.25)
  • ISIN: INE013V01011
  • Distribution Numbers: 14001793 to 14862792
  • Date of Allotment: October 16, 2025
  • Issued to non-promoters on preferential basis
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes. This is a routine listing notification.

Compliance Requirements

Trading members must note the lock-in provisions applicable to the newly listed shares:

  • 336,000 shares (Dist. Nos. 14001793-14337792): Lock-in until August 14, 2026
  • 372,000 shares (Dist. Nos. 14337793-14709792): Lock-in until August 15, 2026
  • 153,000 shares (Dist. Nos. 14709793-14862792): Lock-in until August 14, 2026

Important Dates

  • Allotment Date: October 16, 2025
  • Trading Commencement: January 21, 2026
  • Lock-in Expiry: August 14-15, 2026 (varies by tranche)

Impact Assessment

The listing represents a routine corporate action with minimal market impact. The 861,000 shares issued through warrant conversion increase the company’s equity base modestly. All shares are subject to lock-in periods of approximately 7 months from the trading commencement date, limiting immediate liquidity impact. This is a standard preferential allotment to non-promoters with no immediate trading implications beyond the normal listing process.

Impact Justification

Routine listing of equity shares from warrant conversion on preferential basis with standard lock-in provisions. Limited market impact given the relatively small number of shares.